Herbert Opitz
Overview
Explore the profile of Herbert Opitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cappellini M, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, et al.
Clin Ther
. 2007 Aug;
29(5):909-917.
PMID: 17697909
Background: Iron chelation therapy (ICT) with deferoxamine (DFO), the current standard for the treatment of iron overload in patients with transfusion-dependent disorders such as beta-thalassemia, requires regular subcutaneous or intravenous...
2.
Piga A, Galanello R, Forni G, Cappellini M, Origa R, Zappu A, et al.
Haematologica
. 2006 Jul;
91(7):873-80.
PMID: 16818273
Background And Objectives: Iron accumulation is an inevitable consequence of chronic blood transfusions and results in serious complications in the absence of chelation treatment to remove excess iron. Deferoxamine (Desferal,...
3.
Cappellini M, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al.
Blood
. 2005 Dec;
107(9):3455-62.
PMID: 16352812
Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to demonstrate the efficacy...